Celling Biosciences has officially stepped into women’s health by acquiring ThermiGen a company that develops products such as their flagship product, ThermiRF®, a platform technology that uses temperature as an endpoint for various non-invasive and minimally-invasive applications. Celling will incorporate the Thermi product line as part of its expansion into the women’s health and aesthetics markets.

To read more, visit THIS article.